Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly just joined the Disruptive Innovations speaking faculty where he will provide an opening address on:
Disruptive Innovation: Moving Beyond the Talk
- A case for action to move beyond incremental improvement
- Concrete opportunities for disruptive innovation in clinical development
- Are you on board? The tide is rising.
No comments:
Post a Comment